Business Context and Reporting Period
Company: Abbott Laboratories
Filing Type: Form 8-K (Current Report)
Date of Report: October 19, 2011
Reporting Period: Third Quarter 2011
This filing announces the results of operations for the third quarter of 2011. The detailed financial data is contained in a press release furnished as Exhibit 99.1, which is incorporated by reference.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are located in the referenced Exhibit 99.1 (Press Release).
The company utilizes non-GAAP financial measures to evaluate ongoing business performance. These measures adjust for unusual or unpredictable factors, including:
- Acquisition-related costs and acquired in-process research and development
- Asset impairments and restructuring/cost reduction initiatives
- Currency devaluations and legislative reforms
- Product recalls, withdrawals, and litigation reserves
- Tax audit settlements
- Effects of changes in the calendar year-end for international operations
Material Changes
The filing text does not explicitly detail material changes versus the prior comparable period. Investors must refer to the incorporated press release (Exhibit 99.1) for specific year-over-year comparisons and operational changes.
Guidance, Outlook, and Risks
Management Commentary: Management believes non-GAAP measures provide useful information for evaluating ongoing performance and are used internally to monitor business results. However, the company cautions that these measures should be considered in addition to, and not as a substitute for, GAAP financial measures.
Risks and Contingencies: The filing highlights that results are subject to volatility from specific items such as litigation reserves, product recalls, currency fluctuations, and legislative reforms.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q3 2011 revenue, net earnings, and diluted earnings per share figures.
- Compare GAAP results against non-GAAP adjusted results to understand the impact of one-time items.
- Verify the specific dollar amounts attributed to acquisition costs, impairments, and restructuring charges mentioned in the press release.
- Check for any updated full-year guidance provided in the referenced press release.